Efficacy, Tolerability and Safety of Intramuscular Injections of PLX PAD for the Treatment of Subjects With Critical Limb Ischemia (CLI) With Minor Tissue Loss Who Are Unsuitable for Revascularization
PHASE3
This will be a randomized, placebo-controlled, parallel group, multicenter,...
Status
Completed
Location
UCI Medical Center 101 The City Drive S. Bldg 55 Rm 334 Orange, CA 92868
Phase 1B/2 Clinical Trial Assessing the Safety, Tolerability and Preliminary Efficacy of the Intravenous Administration of Allogeneic Placental Mesenchymal Cells for the Preemptive Treatment of Patients At Risk for Acute Kidney Injury Following Cardiac Surgery
PHASE1
This clinical trial is designed to evaluate KELI-101 versus placebo for the...